Amanote Research
Register
Sign In
Single‐Agent Paclitaxel in the Treatment of Advanced Non‐Small Cell Lung Cancer
Oncologist
- United States
doi 10.1634/theoncologist.4-5-408
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Medicine
Oncology
Date
October 1, 1999
Authors
Mark A. Socinski
Publisher
Alphamed Press
Related search
First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Afatinib Treatment in Advanced Non-Small Cell Lung Cancer
Lung Cancer: Targets and Therapy
Oncology
Single Tube Liquid Biopsy for Advanced Non‐small Cell Lung Cancer
International Journal of Cancer
Cancer Research
Oncology
Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Redefining Treatment Paradigms in First-Line Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Advanced Non-Small Cell Lung Cancer in Elderly Patients
Breathe
Pulmonary
Respiratory Medicine
Commentary on “Gemcitabine: Single‐Agent and Combination Therapy in Non‐Small Cell Lung Cancer”
Oncologist
Cancer Research
Medicine
Oncology
Developments in the Management of Advanced Non Small Cell Lung Cancer
Journal of Cancer Therapy
Cost Effectiveness of Treatment With New Agents in Advanced Non-Small-Cell Lung Cancer
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
